TSE:MFC

Manulife Financial (MFC.TO)

61.99
-1.82 (2.85%)
as of Oct 23, 2026, 8:00:00 pm Market Closed.
1633 watching
0
BUY
Within a year you could see this stock north of $10. Solidified balance sheet, have all the capital they need. They have more credibility here. Delivered better numbers the last two quarters. Good international diversification. It’s the high-risk play in the financials.
BUY
$24 model price. He still recommends it. Add on any dips.
PAST TOP PICK
(Top Pick Mar 16/10, Down 13.90%) Still likes it. Thinks as interest rates and bond yields go up, they will make much more from assets under management. Doesn’t think their interests in Japan are material to their results. Investors are unduly negative on the stock.
DON'T BUY
Stock has been struggling for the last little while. Resistance at current levels. Out of the period of seasonal strength. Between Oct and Jan is it’s strong time. Different than banks, which are Feb to May. Stay away for now.
WEAK BUY
Their exposure to Japan shouldn’t be much. In the short term, he prefers banks over life companies.
PAST TOP PICK
(Top Pick Apr. 19/10, Down 7.21%) Well-known story, has recovered somewhat, but pulled back very recently. Unhedged to the market and had a billion and a half of product that they had to guarantee. In 12 to 18 months you might see a dividend increase. They have covered the hedge to more than half of where it was.
DON'T BUY
In the event of a market correction, they might benefit because of all the hedging they have done. To him, a permanent marker against them is their error in writing unhedged insurance premiums.
HOLD
Historically they have taken too much risk and not hedged enough on their balance sheet. If you have a 2-year horizon, this is a good entry point.
DON'T BUY
Doesn’t own their equities but does own their bonds. Not his favourite name. Quite a valuation discount compared to other Cdn lifecos. Management track record is not as good as others so valuation difference is warranted.
BUY
Doesn’t expect they will raise dividends, as they are worried about battening down the hatches. Were very exposed to the equity and bond markets but are less vulnerable now. They are hoping for a 32% ROE. Great assets in Asia, which will be their growth profile. Mid $20’s in the next year or two would be appropriate.
HOLD
Has recovered off the bottom quite nicely. They are definitely de-risking their business. Have to get back to operating their core operations of insurance and wealth management. Will get a higher multiple with more stable earnings. Good long-term hold.
BUY
Benefiting from 3 things. 1) as bond yields go up insurance companies make more money 2) took a huge hit from their stock market exposure and as the market goes up they can unwind those losses and 3) their life insurance business continues to grow in Asia.
WAIT
Resistance at mid ’09 level, which we are almost at. He would rather pay more and have it break above.
BUY
With the stock market and bond yields going up, the stock price is going up. In terms of valuation, if you take out their Asian life insurance business, you get the North American business for free. Looks like it is recovering and you get a 2.7% yield while you wait.
SELL
Because of the derivatives they’ve created, it is highly leveraged to the stock market. If the market heads down this will have extra leverage to the downside. If you own, consider taking profits now.
Showing 1,336 to 1,350 of 2,287 entries